Electromagnetic hypersensitivity (EHS) is a phenomenon characterized by the appearance of symptoms after exposure of people to electromagnetic fields, generated by EHS is characterized as a syndrome with a broad spectrum of non-specific multiple organ symptoms including both acute and chronic inflammatory processes located mainly in the skin and nervous systems, as well as in respiratory, cardiovascular systems, and musculoskeletal system. WHO does not consider the EHS as a disease-- defined on the basis of medical diagnosis and symptoms associated with any known syndrome. The symptoms may be associated with a single source of EMF or be derived from a combination of many sources.
Understand that metal implants only enhance this issue!
https://pubmed.ncbi.nlm.nih.gov/27012122/
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent ZBH News
- Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026 • PR Newswire (US) • 05/22/2026 08:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 07:19:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 06:47:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 10:30:17 AM
- Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End • PR Newswire (US) • 05/12/2026 10:30:00 AM
- Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference • PR Newswire (US) • 05/06/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:08:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/01/2026 09:11:37 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 06:48:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 10:33:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 10:30:16 AM
- Zimmer Biomet Announces First Quarter 2026 Financial Results • PR Newswire (US) • 04/28/2026 10:30:00 AM
- Zimmer Biomet Announces Chief Financial Officer Transition • PR Newswire (US) • 04/28/2026 10:29:00 AM
- Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results • PR Newswire (US) • 04/09/2026 11:30:00 AM
- Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer • PR Newswire (US) • 04/07/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:03:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:20:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:19:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:18:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:17:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:17:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:16:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:13:58 PM
